Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$624.65M
Total Bought:
$124.83M
Total Sold:
$137.94M
Net Transaction:
-$13.12M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
2,880,8803,006,980+126,100$110.51M$86.72M13.88%-$23.79M
Verona Pharma PlcADS1,895,2001,835,200-60,000$27.40M$52.80M8.45%+$25.39M
Structure Therapeutics IncADS1,140,0601,198,000+57,940$44.77M$52.58M8.42%+$7.81M
Dianthus Therapeutics, Inc.(DNTH)1,746,6671,746,6670$45.20M$47.82M7.66%+$2.62M
ArriVent BioPharma, Inc.(AVBP)1,803,3041,976,387+173,083$33.45M$46.45M7.44%+$12.99M
Centessa Pharmaceuticals PlcADS2,345,0752,012,052-333,023$21.18M$32.17M5.15%+$11.00M
Insmed Incorporated(INSM)650,216436,820-213,396$43.56M$31.89M5.10%-$11.68M
Nuvation Bio Inc.CL A(NUVB)431,60012,171,513+11,739,913$1.26M$27.87M4.46%+$26.61M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)488,0001,115,000+627,000$22.08M$23.00M3.68%+$920.5K
Ocular Therapeutix, Inc.(OCUL)2,425,0002,425,0000$16.59M$21.10M3.38%+$4.51M
Viridian Therapeutics, Inc.(VRDN)620,000870,000+250,000$8.07M$19.79M3.17%+$11.73M
Perspective Therapeutics, Inc.(CATX)1,580,2491,422,224-158,025$15.76M$18.99M3.04%+$3.23M
Mind Medicine Mindmed Inc2,153,0003,018,000+865,000$15.52M$17.17M2.75%+$1.65M
Cogent Biosciences, Inc.(COGT)01,305,000+1,305,000$0$14.09M2.26%+$14.09M
BridgeBio Pharma, Inc.(BBIO)690,000552,000-138,000$17.48M$14.05M2.25%-$3.42M
Pharvaris N V
COM
0620,470+620,470$0$11.49M1.84%+$11.49M
Dyne Therapeutics, Inc.(DYN)1,180,798262,726-918,072$41.67M$9.44M1.51%-$32.23M
Taysha Gene Therapies, Inc.(TSHA)4,572,2224,572,2220$10.24M$9.19M1.47%-$1.05M
Gossamer Bio, Inc.(GOSS)9,187,8839,187,8830$8.28M$9.06M1.45%+$785.6K
Allovir Inc9,800,00011,202,000+1,402,000$7.09M$9.06M1.45%+$1.97M
EyePoint, Inc.(EYPT)1,093,5031,093,5030$9.51M$8.74M1.40%-$776.4K
Praxis Precision Medicines, Inc.(PRAX)260,000130,000-130,000$10.75M$7.48M1.20%-$3.27M
Mineralys Therapeutics, Inc.(MLYS)600,000600,0000$7.02M$7.27M1.16%+$246.0K
Regulus Therapeutics Inc4,263,7014,263,7010$7.61M$6.69M1.07%-$916.7K
Ventyx Biosciences Inc2,391,1142,391,1140$5.52M$5.21M0.83%-$310.8K
Tenaya Therapeutics, Inc.(TNYA)2,576,2002,576,2000$7.99M$4.97M0.80%-$3.01M
Cybin D/B/A Helus Pharma(HELP)0489,596+489,596$0$4.35M0.70%+$4.35M
Reneo Pharmaceuticals Inc2,250,0002,250,0000$3.40M$3.83M0.61%+$427.5K
Unicycive Therapeutics Inc08,559,000+8,559,000$0$3.49M0.56%+$3.49M
PepGen Inc.(PEPG)376,117376,1170$6.00M$3.22M0.51%-$2.79M
Helix Acquisition Corp IiCL A250,000250,0000$2.56M$2.61M0.42%+$57.5K
Black Diamond Therapeutics I0594,000+594,000$0$2.58M0.41%+$2.58M
Annexon, Inc.(ANNX)400,000400,0000$1.96M$2.37M0.38%+$408.0K
Mersana Therapeutics Inc992,000992,0000$1.99M$1.87M0.30%-$119.0K
Century Therapeutics, Inc.(IPSC)1,333,650666,825-666,825$3.40M$1.14M0.18%-$2.26M
Aerovate Therapeutics Inc465,440465,4400$772.6K$972.8K0.16%+$200.1K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)0312,336+312,336$0$715.2K0.11%+$715.2K
Autolus Therapeutics plcADS(AUTL)176,000176,0000$612.5K$638.9K0.10%+$26.4K
Neurogene Inc.(NGNE)015,000+15,000$0$629.4K0.10%+$629.4K
Rapt Therapeutics Inc292,000292,0000$890.6K$586.9K0.09%-$303.7K
Nkarta, Inc.(NKTX)240,000120,000-120,000$1.42M$542.4K0.09%-$876.0K
Adicet Bio Inc767,7990-767,799$929.0K$0—-$929.0K
Akero Therapeutics Inc283,3720-283,372$6.65M$0—-$6.65M
An2 Therapeutics Inc3,220,2630-3,220,263$6.92M$0—-$6.92M
Cybin D/B/A Helus Pharma(HELP)18,604,6500-18,604,650$5.04M$0—-$5.04M
Elevation Oncology Inc747,0000-747,000$2.02M$0—-$2.02M
Fate Therapeutics, Inc.(FATE)520,8000-520,800$1.71M$0—-$1.71M
Jasper Therapeutics, Inc.(JSPR)287,5000-287,500$6.53M$0—-$6.53M
Poseida Therapeutics Inc736,0000-736,000$2.15M$0—-$2.15M
Silence Therapeutics plcADS(SLN)176,0000-176,000$3.34M$0—-$3.34M
Terns Pharmaceuticals Inc1,364,4000-1,364,400$9.29M$0—-$9.29M
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q3 2024 | TickerTrail